Swedencare AB (publ) Logo

Swedencare AB (publ)

Develops and markets premium health supplements and pharmaceuticals for cats, dogs, and horses.

SECARE | ST

Overview

Corporate Details

ISIN(s):
SE0015988167
LEI:
549300FZT7YIF6SWX789
Country:
Sweden
Address:
C/O Medeon Science Park, 205 12 Malmö
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Swedencare AB is a global group that develops, produces, and markets premium pet health products, primarily for cats, dogs, and horses. The company's portfolio includes a range of strong brands offering supplements, natural and organic products, and specialty pharmaceuticals. A key component of its growth strategy is the acquisition of established companies to expand its market presence and product offerings. Swedencare utilizes a multi-channel distribution model, selling its products through a global network of veterinary clinics, pet stores, and leading e-commerce platforms like Amazon and Chewy. The company focuses on innovation and aims to outperform market growth by meeting the increasing consumer demand for high-quality pet care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Swedencare AB (publ) filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Swedencare AB (publ)

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Swedencare AB (publ) via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-24 Thomas Eklund Other Buy 12,560 426,412.00 SEK
2025-01-08 Laszlo Janos Varga Other Buy 500 22,550.00 SEK
2025-01-07 Laszlo Janos Varga Other Buy 500 23,420.00 SEK

Peer Companies

INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America
INO
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America
INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America
TIL
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel
INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden
IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea
048530
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD

Talk to a Data Expert

Have a question? We'll get back to you promptly.